Translating ATP III Cholesterol Management Guidelines *

翻译 ATP III 胆固醇管理指南 *

• 批准号: 7118813
• 负责人: CHARLES B EATON
• 金额: $ 3.53万
• 依托单位: MEMORIAL HOSPITAL OF RHODE ISLAND
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-09-10 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7118813
• 关键词: behavioral /social science research tag; blood lipoprotein; cardiovascular disorder education; cholesterol; clinical research; educational resource design /development; health behavior; health care personnel performance; health care service evaluation; health services research tag; human subject; low density lipoprotein; outcomes research; patient care management; primary care physician; training

DESCRIPTION (provided by the applicant): This project will demonstrate and evaluate the translation of the ATP III Cholesterol management guidelines into primary care practice. During phase 1, a needs assessment will evaluate barriers and facilitators to implementation of ATP III guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from semi-structured individual interviews of patients and providers and participant observation during pilot testing in 10 primary care practices, three tools will be refined and tailored: a computerized patient activation tool based upon NHLBI web-based 10-year CHD risk score that will be placed in each primary care office's waiting room for patient use; an ATP III interactive guidelines tool for hand held device (PDA) to be used by primary care providers as a decision support tool at the point of care and academic detailing materials consisting of a practice manual, interactive, powerpoint slides, and practice materials to be used during a academic detailing session. During phase 2, a block, randomized designed cluster trial will be performed with one year of intervention within primary care practices (24 practices/48 providers) throughout the state of Rhode Island and Southeastern New England to test the effectiveness of the materials developed in phase 1 to improve physician performance around ATP III guideline implementation and to improve clinically relevant outcomes, the percentage of patients with LDL-cholesterol at their ATP III goal. Products for dissemination from this grant will include the results of the focus groups barriers and facilitators to implementation of ATP III guidelines findings, a MedQuest module for quality of care assessment regarding ATP III guidelines, refined computerized patient activation tool, tailored ATP III interactive guideline tool for PDA, tailored academic detailing materials and results of randomized clinical trial on the effectiveness of these tools to improve primary care practice.

描述（由申请人提供）： 该项目将展示和评估ATP III胆固醇管理指南转化为初级保健实践。在第1阶段，将通过初级保健患者和提供者的重点小组，进行需求评估，以评估在临床实践中实施ATP III指南的障碍和促进因素。通过对患者和医疗服务提供者的半结构化个人访谈的形成性评价和反馈，以及在10个初级保健实践中进行试点测试期间的参与者观察，将改进和调整三种工具：基于NHLBI基于网络的10年CHD风险评分的计算机化患者激活工具，将放置在每个初级保健办公室的候诊室供患者使用;用于手持设备（PDA）的ATP III交互式指南工具，由初级保健提供者用作护理点的决策支持工具，以及学术详细资料，包括实践手册、交互式PowerPoint幻灯片和学术详细会议期间使用的实践材料。在第2阶段，将在初级保健实践中进行为期一年的干预，在整个罗得岛州和东南部新英格兰（24个实践/48个提供者）测试第1阶段开发的材料的有效性，以提高医生在ATP III指南实施方面的表现，并改善临床相关结果，LDL-胆固醇达到ATP III目标的患者百分比。 该补助金的传播产品将包括焦点小组的结果，ATP III指南实施的障碍和促进者，关于ATP III指南的护理质量评估的MedQuest模块，完善的计算机化患者激活工具，PDA定制的ATP III交互式指南工具，量身定制的学术详细材料和随机临床试验的结果，这些工具的有效性，以改善基层医疗实践。